Taxus Cardium Pharmaceuticals Grp Inc (CRXM)

HEALTH CARE: HEALTH CARE SUPPLIES
SIC: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

11750 SORRENTO VALLEY ROAD SAN DIEGO, CA 92121

Cardium Therapeutics is a medical technology company primarily focused on the development, manufacture and sale of products for cardiovascular and related indications. Co.'s portfolio of product candidates include Generx, a DNA-based growth factor therapeutic for the treatment to promote and stimulate the growth of collateral circulation in the hearts of patients with ischemic conditions; and Corgentin, a pre-clinical DNA-based therapeutic for administration in acute care setting for heart attack patients. It also develops Genvascor, a pre-clinical DNA-based therapeutic designed for the treatment of patients with critical limb ischemia due to advanced peripheral arterial occlusive disease.

Data as of 2021-09-11 10:41:07 -0400
Market Cap709.981 Thousand Shares Outstanding14.489 Million Avg 30-day Volume147.228 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS0
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE Enterprise Value
Total Cash Current Debt Gross Profit
BETA0.0 52-week High/Low0.1 / 0.0245 Next Earnings Date Price to Cash FLow (P/CF) -9999999.0
Data provided by IEX Cloud
View SEC Filings from CRXM instead.

View recent insider trading info

Funds Holding CRXM (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding CRXM BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

JEMAPETE CHRISTOPHER J

  • 10% Owner
No longer subject to file 2021-03-31 3

GRAINER JAMES L CHAIRMAN OF THE BOARD & CFO

  • Officer
  • Director
0 2020-05-22 0

MULYE NIRMAL

  • 10% Owner
0 2020-05-22 0

NOSTRUM PHARMACEUTICALS, LLC

  • 10% Owner
0 2020-05-22 0

VYAS KAUSHIK K.

  • Director
0 2020-05-22 0

SHEBUSKI RONALD J. CHIEF SCIENTIFIC OFFICER

  • Officer
0 2020-05-22 0

REINHARD CHRISTOPHER J CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
0 2015-03-23 0

HUTCHISON MURRAY H

  • Director
0 2015-03-23 0

LEWIS GERALD J

  • Director
0 2015-03-23 0

LEITCH ANDREW M

  • Director
0 2015-03-23 0

GABRIELSON EDWARD W

  • Director
0 2015-03-23 0

OTREMBA LON E

  • Director
0 2015-03-23 0

MULROY DENNIS CHIEF FINANCIAL OFFICER

  • Officer
0 2014-02-28 0

DYLAN TYLER MICHAEL CHIEF BUSINESS OFFICER

  • Officer
  • Director
0 2014-02-28 0

RUBANYI GABOR M CHIEF SCIENTIFIC OFFICER

  • Officer
0 2014-02-28 0

SIMON RONALD I

  • FORMER DIRECTOR
No longer subject to file 2009-01-22 0

MOREADITH RANDALL

  • FORMER EXEC. VP AND CMO
No longer subject to file 2008-08-05 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
TAXUS CARDIUM PHARMACEUTICAL CRXM 2021-09-17 22:15:03 UTC -0.8095 0.8795 1400000
TAXUS CARDIUM PHARMACEUTICAL CRXM 2021-09-17 21:45:03 UTC -0.8095 0.8795 1400000
TAXUS CARDIUM PHARMACEUTICAL CRXM 2021-09-17 21:15:04 UTC -0.8095 0.8795 1400000
TAXUS CARDIUM PHARMACEUTICAL CRXM 2021-09-17 20:45:03 UTC -0.8095 0.8795 1400000
TAXUS CARDIUM PHARMACEUTICAL CRXM 2021-09-17 20:15:05 UTC -0.8095 0.8795 1400000
TAXUS CARDIUM PHARMACEUTICAL CRXM 2021-09-17 19:45:03 UTC -0.8095 0.8795 1400000
TAXUS CARDIUM PHARMACEUTICAL CRXM 2021-09-17 19:15:03 UTC -0.8095 0.8795 1400000
TAXUS CARDIUM PHARMACEUTICAL CRXM 2021-09-17 18:45:03 UTC -0.8095 0.8795 1400000
TAXUS CARDIUM PHARMACEUTICAL CRXM 2021-09-17 18:15:03 UTC -0.8095 0.8795 1400000
TAXUS CARDIUM PHARMACEUTICAL CRXM 2021-09-17 17:45:03 UTC -0.8095 0.8795 1400000
TAXUS CARDIUM PHARMACEUTICAL CRXM 2021-09-17 17:15:03 UTC -0.8095 0.8795 1400000
TAXUS CARDIUM PHARMACEUTICAL CRXM 2021-09-17 16:45:03 UTC -0.8095 0.8795 1400000
TAXUS CARDIUM PHARMACEUTICAL CRXM 2021-09-17 16:15:02 UTC -0.8095 0.8795 1400000
TAXUS CARDIUM PHARMACEUTICAL CRXM 2021-09-17 15:45:02 UTC -0.8095 0.8795 1400000
TAXUS CARDIUM PHARMACEUTICAL CRXM 2021-09-17 15:15:03 UTC -0.8095 0.8795 1400000
TAXUS CARDIUM PHARMACEUTICAL CRXM 2021-09-17 14:45:03 UTC -0.8095 0.8795 1400000
TAXUS CARDIUM PHARMACEUTICAL CRXM 2021-09-17 14:15:03 UTC -0.8095 0.8795 1400000
TAXUS CARDIUM PHARMACEUTICAL CRXM 2021-09-17 13:45:02 UTC -0.8095 0.8795 1400000
TAXUS CARDIUM PHARMACEUTICAL CRXM 2021-09-17 13:15:03 UTC -0.8095 0.8795 1400000
TAXUS CARDIUM PHARMACEUTICAL CRXM 2021-09-17 12:45:03 UTC -0.8095 0.8795 1400000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments